Jacob A. Eitel

发表

PTEN and p53 are required for hypoxia induced expression of maspin in glioblastoma cells

Karen E. Pollok, K. Pollok, L. Mayo, 2009, Cell cycle.

Serdemetan Antagonizes the Mdm2-HIF1α Axis Leading to Decreased Levels of Glycolytic Enzymes

L. Mayo, J. Lehman, Christopher N. Batuello, 2013, PloS one.

Therapeutic considerations for Mdm2: not just a one trick pony

L. Mayo, J. Lehman, Christopher N. Batuello, 2008, Expert opinion on drug discovery.

TGF-β1–induced expression of human Mdm2 correlates with late-stage metastatic breast cancer

Xian-Jin Xie, K. Pollok, L. Mayo, 2020 .

TGF-b 1 – induced expression of human Mdm 2 correlates with late-stage metastatic breast cancer

Xian-Jin Xie, K. Pollok, L. Mayo, 2019 .

TGF-beta1-induced expression of human Mdm2 correlates with late-stage metastatic breast cancer.

Xian-Jin Xie, K. Pollok, L. Mayo, 2010, The Journal of clinical investigation.

Combination therapy in a xenograft model of glioblastoma: enhancement of the antitumor activity of temozolomide by an MDM2 antagonist.

J. Sarkaria, C. Wells, K. Pollok, 2017, Journal of neurosurgery.

Estimation of radiation dosimetry for 68Ga-HBED-CC (PSMA-11) in patients with suspected recurrence of prostate cancer.

G. Hutchins, J. Fletcher, M. Green, 2017, Nuclear medicine and biology.

Whole-Body PET/CT Evaluation of Tumor Perfusion Using Generator-Based 62Cu-Ethylglyoxal Bis(Thiosemicarbazonato)Copper(II): Validation by Direct Comparison to 15O-Water in Metastatic Renal Cell Carcinoma

G. Hutchins, J. Fletcher, M. Green, 2015, The Journal of Nuclear Medicine.